Author

Gillian Beaton

Observed name: G. Beaton

Institution: NHS Greater Glasgow and Clyde

Observed institutions: Canterbury Christ Church University, NHS Greater Glasgow and Clyde, Wake Forest University Health Sciences, Wake Forest University

ORCID: 0000-0002-8539-9318

Observed ORCID: 0000-0002-8539-9318

OpenAlex ID: A5010057952

Prediction of disability-free survival in healthy older people

2022 · Johannes Tobias Neumann, Le T. P. Thao, et al. · GeroScience · 36

Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson’s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial

2024 · Catherine M Sackley, Caroline Rick, et al. · BMJ · 17

The effect of two speech and language approaches on speech problems in people with Parkinson’s disease: the PD COMM RCT

2024 · Catherine M Sackley, Caroline Rick, et al. · Health Technology Assessment · 6

A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial

2020 · on behalf of the PD COMM Collaborative Group, C. M. Sackley, et al. · Trials · 6

The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's‐Related Dysarthria

2025 · Avril Nicoll, Marian C. Brady, et al. · International Journal of Language & Communication Disorders · 1

Works count: 5

Citation count: 66

H-index: 4

I10-index: 2